Article
Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta‐Analysis
1 Jan 2022
Abstract excerpt
Objective . Antiphospholipid syndrome (APS) is a chronic autoimmune disease with a high prevalence in females. Published data have identified pregnant women with APS may suffer from recurrent miscarriage, fetal death. However, the association between antiphospholipid antibody (aPL) and fetal growth restriction (FGR) remains controversial. This study aims to systematically review the literature on population‐based...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
